Affiliation:
1. Drug Research Institute, 1137 Budapest, Hungary
2. Department of Criminal Psychology, University of Public Service, 1082 Budapest, Hungary
Abstract
Endocannabinoids were implicated in a variety of pathological conditions including anxiety and are considered promising new targets for anxiolytic drug development. The optimism concerning the potentials of this system for anxiolysis is probably justified. However, the complexity of the mechanisms affected by endocannabinoids, and discrepant findings obtained with various experimental approaches makes the interpretation of research results difficult. Here, we review the anxiety-related effects of the three main interventions used to study the endocannabinoid system: pharmacological agents active at endocannabinoid-binding sites present on both the cell membrane and in the cytoplasm, genetic manipulations targeting cannabinoid receptors, and function-enhancers represented by inhibitors of endocannabinoid degradation and transport. Binding-site ligands provide inconsistent findings probably because they activate a multitude of mechanisms concomitantly. More robust findings were obtained with genetic manipulations and particularly with function enhancers, which heighten ongoing endocannabinoid activation rather than affecting all mechanisms indiscriminately. The enhancement of ongoing activity appears to ameliorate stress-induced anxiety without consistent effects on anxiety in general. Limited evidence suggests that this effect is achieved by promoting active coping styles in critical situations. These findings suggest that the functional enhancement of endocannabinoid signaling is a promising drug development target for stress-related anxiety disorders.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference204 articles.
1. Isolation and structure of a brain constituent that binds to the cannabinoid receptor;Devane;Science,1992
2. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors;Mechoulam;Biochem. Pharmacol.,1995
3. Rezende, B., Alencar, A.K.N., de Bem, G.F., Fontes-Dantas, F.L., and Montes, G.C. (2023). Endocannabinoid System: Chemical Characteristics and Biological Activity. Pharmaceuticals, 16.
4. Determination and characterization of a cannabinoid receptor in rat brain;Devane;Mol. Pharmacol.,1988
5. Molecular characterization of a peripheral receptor for cannabinoids;Munro;Nature,1993
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献